null
ChEBI ID: 38187
| Member | Definition | Role |
|---|---|---|
| 3-pyridinaldehyde | A pyridinecarbaldehyde that is pyridine substituted by a formyl group at position 3. | pyridine-3-carbaldehyde |
| pyridine-2-carboxaldehyde | A pyridinecarbaldehyde that is pyridine in which the hydrogen at position 2 is replaced by a formyl group. | 2-formylpyridine |
| pyridoxal | A pyridinecarbaldehyde that is pyridine-4-carbaldehyde bearing methyl, hydroxy and hydroxymethyl substituents at positions 2, 3 and 5 respectively. The 4-carboxyaldehyde form of vitamin B6, it is converted into pyridoxal phosphate, a coenzyme for the synthesis of amino acids, neurotransmitters, sphingolipids and aminolevulinic acid. | pyridoxal |
| pyridoxal phosphate | The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal. | pyridoxal 5'-phosphate |
| pyridoxal phosphate | Pyridoxal 5-phosphate monohydrate | |
| pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid | An arenesulfonic acid that is pyridoxal 5'-phosphate carrying an additional 2,4-disulfophenylazo substituent at position 6. | 5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3,629 (50.66) | 18.7374 |
| 1990's | 1,185 (16.54) | 18.2507 |
| 2000's | 1,195 (16.68) | 29.6817 |
| 2010's | 853 (11.91) | 24.3611 |
| 2020's | 302 (4.22) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 154 (1.84%) | 5.53% |
| Reviews | 388 (4.64%) | 6.00% |
| Case Studies | 139 (1.66%) | 4.05% |
| Observational | 6 (0.07%) | 0.25% |
| Other | 7,668 (91.78%) | 84.16% |